← Eichor
Study identifier: NCT06363253 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pilot Study of the Human Metagenome in Metabolic Diseases

Condition: Obesity · Sarcopenia · Sarcopenic Obesity  ·  Sponsor: Sengkang General Hospital

PhaseN/A
Planned participants600
Who can joinAll sexes, 21 Years to 99 Years
Healthy volunteersYes

About this study

This is a cohort study to understand the role of the human metagenome, and associated metabolites, in health and in various diseased states, in particular obesity as well as sarcopenia. Recruited participants will have their fecal, salivary, urine, serum, and in certain instances, mucosal samples taken, for metagenomic sequencing and metabolite testing. We hope to uncover various differences and signatures in the metagenome and metabolome in various diseased states, with potential future therapeutic applications in personalised medicine.

This description comes directly from the study's public registry record.

Talk to the study team

Koy Min Chue  ·  69305000  ·  chue.koy.min@singhealth.com.sg

Always discuss trial participation with your own doctor first.

Locations (1)

Sengkang General HospitalSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06363253